학술논문
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
Document Type
Article
Author
Himmelbauer, M.K.; Bajrami, B.; Basile, R.; Capacci, A.; Chen, T.; Choi, C.K.; Gilfillan, R.; Gonzalez-Lopez de Turiso, F.; Gu, C.; Hoemberger, M.; Johnson, D.S.; Jones, J.H.; Kadakia, E.; Kirkland, M.; Lin, E.Y.; Liu, Y.; Ma, B.; Magee, T.; Mantena, S.; Marx, I.E.; Metrick, C.M.; Mingueneau, M.; Murugan, P.; Muste, C.A.; Nadella, P.; Nevalainen, M.; Parker Harp, C.R.; Pattaropong, V.; Pietrasiewicz, A.; Prince, R.J.; Purgett, T.J.; Santoro, J.C.; Schulz, J.; Sciabola, S.; Tang, H.; Vandeveer, H.G.; Wang, T.; Yousaf, Z.; Helal, C.J.; Hopkins, B.T.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 23 May 2024, 67(10):8122-8140)
Subject
Language
English
ISSN
15204804
00222623
00222623